Neola Medical’s expansion in the U.S. market is gaining momentum, with significant progress in launch preparations. As part of the company’s strategy to leverage U.S. market expertise, Neola Medical has appointed Monica Alfaro Welling as its first American board...
Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently preparing for clinical validation of Neola®. BioStock has contacted David to find out more about his...
“This is a step towards optimizing the conditions for a successful clinical study on preterm born infants in the U.S.”, says CEO anna Sjöström After recently obtaining the CB certificate for its medical device, Neola Medical is now intensively preparing...
The company’s product for continuous lung monitoring of preterm born infants is attracting significant international interest. Watch CEO Hanna Sjöström and CEO Oscar Ahlgren at Västra Hamnen TV discuss Neola Medical’s promising study data, the substantial...
The second quarter of 2024 marked several milestones towards achieving market approval in the U.S. Notably, the company’s medical device received CB certification, indicating that Neola®meets the required technical safety standards. Clinical trials are now on...
Did you miss all the exciting updates when CEO Hanna Sjöström and CFO Christian Gyllenberg presented Neola Medical’s Q2-report of 2024 at Finwire TV? Learn more about the company’s financial position and the important key achievements from this quarter, aimed at...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
